NEUROMETRIX INC (NURO) Stock Price, Quote, News and Overview
NASDAQ:NURO - Nasdaq - US6412558800 - Common Stock - Currency: USD
NURO Quote, Performance and Key Statistics
NASDAQ:NURO (4/22/2025, 8:23:57 PM)
4.35
+0.03 (+0.69%)
The current stock price of NURO is 4.35 USD. In the past month the price decreased by -3.55%. In the past year, price decreased by -2.03%.
NURO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.56 | 228.46B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.31 | 171.52B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.87 | 140.59B | ||
| SYK | STRYKER CORP | 28.56 | 132.87B | ||
| MDT | MEDTRONIC PLC | 15.61 | 106.93B | ||
| BDX | BECTON DICKINSON AND CO | 14.37 | 57.39B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.95 | 41.51B | ||
| IDXX | IDEXX LABORATORIES INC | 37.47 | 34.17B | ||
| RMD | RESMED INC | 24.22 | 31.44B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.73 | 28.23B | ||
| DXCM | DEXCOM INC | 40.2 | 26.01B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.38 | 22.69B |
Related stock screener links
About NURO
Company Profile
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. The company is headquartered in Waltham, Massachusetts and currently employs 26 full-time employees. The company went IPO on 2004-07-22. The firm's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The firm has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. The company operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
Company Info
NEUROMETRIX INC
1000 Winter Street
Waltham MASSACHUSETTS 01801 US
CEO: Shai N. Gozani
Employees: 26
Company Website: https://www.neurometrix.com/
Investor Relations: http://investor.neurometrix.com/index.cfm
Phone: 17818909989
NEUROMETRIX INC / NURO FAQ
What is the stock price of NEUROMETRIX INC today?
The current stock price of NURO is 4.35 USD. The price increased by 0.69% in the last trading session.
What is the ticker symbol for NEUROMETRIX INC stock?
The exchange symbol of NEUROMETRIX INC is NURO and it is listed on the Nasdaq exchange.
On which exchange is NURO stock listed?
NURO stock is listed on the Nasdaq exchange.
What is NEUROMETRIX INC worth?
NEUROMETRIX INC (NURO) has a market capitalization of 8.96M USD. This makes NURO a Nano Cap stock.
How many employees does NEUROMETRIX INC have?
NEUROMETRIX INC (NURO) currently has 26 employees.
What are the support and resistance levels for NEUROMETRIX INC (NURO) stock?
NEUROMETRIX INC (NURO) has a support level at 4.35 and a resistance level at 4.36. Check the full technical report for a detailed analysis of NURO support and resistance levels.
Should I buy NEUROMETRIX INC (NURO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NURO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NURO, evaluating the profitability, health, valuation and growth aspects
- NEUROMETRIX INC (NURO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUROMETRIX INC (NURO) Sales and EPS estimates to see what analysts future expectations are.
- NEUROMETRIX INC (NURO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUROMETRIX INC (NURO) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUROMETRIX INC (NURO) Stock Chart to make your own analysis
- NEUROMETRIX INC (NURO) Latest news and press-releases to stay up to date.
Does NEUROMETRIX INC (NURO) stock pay dividends?
NURO does not pay a dividend.
When does NEUROMETRIX INC (NURO) report earnings?
NEUROMETRIX INC (NURO) will report earnings on 2025-05-13.
What is the Price/Earnings (PE) ratio of NEUROMETRIX INC (NURO)?
NEUROMETRIX INC (NURO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.59).
What is the Short Interest ratio of NEUROMETRIX INC (NURO) stock?
The outstanding short interest for NEUROMETRIX INC (NURO) is 0.14% of its float. Check the ownership tab for more information on the NURO short interest.
NURO Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to NURO. When comparing the yearly performance of all stocks, NURO is one of the better performing stocks in the market, outperforming 71.72% of all stocks.
NURO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NURO. While NURO has a great health rating, there are worries on its profitability.
NURO Financial Highlights
Over the last trailing twelve months NURO reported a non-GAAP Earnings per Share(EPS) of -4.59. The EPS decreased by -565.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.65% | ||
| ROE | -48.03% | ||
| Debt/Equity | 0 |
NURO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to NURO. The Buy consensus is the average rating of analysts ratings from 7 analysts.